Suchergebnis | Hamburg Open Science

Facetten

58 Einträge gefunden

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial
2021 - Forschungsinformationssystem des UKE
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age
2020 - Forschungsinformationssystem des UKE
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
2020 - Forschungsinformationssystem des UKE
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression
2017 - Forschungsinformationssystem des UKE
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy
2017 - Forschungsinformationssystem des UKE
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort
2015 - Forschungsinformationssystem des UKE
Salvage Radical Prostatectomy for recurrent Prostate Cancer: Verification of EAU guideline criteria
2015 - Forschungsinformationssystem des UKE
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
2013 - Forschungsinformationssystem des UKE
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
2012 - Forschungsinformationssystem des UKE
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy
2012 - Forschungsinformationssystem des UKE
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
2011 - Forschungsinformationssystem des UKE
Full functional-length urethral sphincter preservation during radical prostatectomy.
2011 - Forschungsinformationssystem des UKE
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.
2011 - Forschungsinformationssystem des UKE
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?
2010 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
2008 - Forschungsinformationssystem des UKE
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
2008 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial

Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression

High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy

External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort

Salvage Radical Prostatectomy for recurrent Prostate Cancer: Verification of EAU guideline criteria

Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Full functional-length urethral sphincter preservation during radical prostatectomy.

Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.